In vivo depletion of CD8+ T cells restores hair growth in the DEBR model for alopecia areata

British Journal of Dermatology

Volumn 135, Issue 2, 1996, Pages 211-217

  McElwee, K J ^a   Spiers, E M ^b   Oliver, R F ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY OX 8; UNCLASSIFIED DRUG;

ALOPECIA AREATA; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HAIR GROWTH; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOCYTE DEPLETION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUPPRESSOR CELL;

EID: 0030003391     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1996.tb01149.x     Document Type: Article

References (33)

1. Perret C. Weisner-Menzel L, Happle R. Immunohistochemical analysis of T-cell subsets in the peribulbar and intrabulbar intiltratcs of alopecia areala. Acta Derm Venereol (Stockh) 1984; 64: 26-30.
2. Ranki AR, Kianto U, Kanerva L, et al. Immunohistochemical and electron microscopic characterization of the cellular intiltrate in alopecia (arcata, totalis and universalis). J Invest Dermatol 1984: 83: 7-11.
3. Ormsby OS, Montgomery H, (eds). Diseases of the Skin, 7th edn. London: Henry Kimpton, 1948; 1365-75.
4. Editorial: Alopecia areata-an autoimmune disease? Lancet 1984: i: 1355-6.
5. Michie HJ, Jahoda CAB, Oliver RF, Poulton TA. Immunobiological sludies on the alopecic (DEBR)rat. Br J Dermatol 1990; 123: 557-67.
6. Michie HJ. Jahoda CAB, Oliver RF. Johnson BE. The DEBR rat: an animal model of human alopecia areata. Br J Dermatol 1991; 125: 94-100.
7. Oliver RF, Jahoda CAB, Horne KA et al. The DEBR rat model for alopecia areata. J Invest Dermatol 1991; 96 (Suppl): 97s (Abstr.).
8. Zhang JG, Oliver RF. Immunohistological study of the development of the cellular infiltrate in the pelage follicles of the DEBR model for alopecia areata. Br J Dermatol 1994; 130: 405-14.
9. McElwee KJ, Pickett P. Oliver RF. Hair follicle autoantibodies in DEBR rat sera, J Invest Dermatol 1995; 104 (Suppl.): 34-5s.
10. McElwee KJ, Pickett P, Oliver RF. Autoantibodies to the hair follicle in sera from the DEBR rat model for alopecia areata. Br J Dermatal 1996; 134: 55-63.
11. Sundberg JP, Oliver RF, McElwee KJ et al. Alopecia areata in humans and other mammalian species. J Invent Dermatol 1995; 104 (Suppl.): 32s-3s.
12. Oliver RF, Lowe JG. Oral cyclosporin A restores hair growth in the DEBR rat model for alopecia areata. Clin Exp Dermatol 1995; 20: 127-31.
13. Ayliffe W. Alam Y. Bell EB et al. Prolongation of rat corneal graft survival by treatment with anti-CD4 monoclonal antibody. Br J Opthalmol 1992; 76: 602-6.
14. Mason DW. Arthur RP, Dallman MJ et al. Functions of rat T-lymphocyte subsets isolated by means of monoclonal antibodies. Immunol Rev 1983: 74: 57-82.
15. + (cytotoxic/suppressor) cells in the immunoregulation of experimental allergic encephatomyelitis. Eur J Immunol 1988; 18: 495-502.
16. Harlow E, Lane D. Antibodies: A Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Laboratory, 1988; 245-81.
17. Roser BJ. Cellular mechanisms in neonatal and adult tolerance. Immunol Rev 1989; 107: 179-202.
18. McDonagh M, Bell EB. The survival and turnover of mature and immature CD8 T cells. Immnology 1995; 84: 514-20.
19. Hordinsky MK, Hallgren H, Nelson D et al. Suppressor cell number and function in alopecia areata. Arch Dermatol 1984; 120: 188-94.
20. Galbraith GMP, Thiers BH, Vasily DB, Fudenberg HH. Immunological profiles in alopecia areata. Br J Dermatol 1984; 110: 163-70.
21. Baadsgaard O, Lindskov R. Circulating lymphocyte subsets in patients with alopecia areata. Acta Derm Venerol (Stockh) 1986; 66: 266-8.
22. Majewski BBJ, Koh MS, Taylor DR et al. Increased ratio of helper to suppressor T cells in alopecia areata. Br J Dermatol 1984; 110: 171-5.
23. Valsecchi R, Bontempelli M, Vicari O et al. Peripheral T-cell subsets in patients with alopecia areata in different clinical phases. Dermatalogica 1985; 171: 170-4.
24. + cells and their roles in the induction and prevention of autoimmunity. Immunol Rev 1991; 123: 37-64.
25. Paus R, Slominski A, Czarnetzki BM. Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class II expression in the anagen hair bulb? Yale J Biol Med 1994; 66: 541-54.
26. Brocker EB, Echternach-Happle K, Hamm H et al. Abnormal expression of class I and class II major histocompatability antigens in alopecia areata: modulation by topical immunotherapy. J Invest Dermatol 1987; 88: 564-8.
27. Westgate GE, Craggs RI, Gibson WT. Immune privilege in hair growth. J Invest Dermatol 1991; 97: 417-20.
28. Paus R, Eichmuller S. Hofmann U et al. Expression of classical and non-classical MHC class I antigens in murine hair follicles. Br J Dermatol 1994; 131: 177-83.
29. Messenger AG, Bleehen SS. Expression of HLA-DR by anagen hair follicles in alopecia areata. J Invest Dermatol 1985; 85: 569-72.
30. Thomson AW, Carroll PB, McCauley J et al. FK 506 a novel immunosuppressant for treatment of autoimmune disease. Springer Semin Immunopathol 1993; 14: 323-44.
31. Roger D, Charmes JP, Bonnetblanc JM. Alopecia areata occurring in a patient receiving systemic cyclosporin A. Acta Derm Venereal (Stoekh) 1994; 74: 154.
32. Davis MG, Bowers PW. Alopecia areata arising in patients receiving cyclosporin immunosuppression. Br J Dermatol 1995; 132: 835-6.
33. Racadot E, Wendung D, Rumbach L et al. Current concepts in the treatment of autoimmune diseases with monoclonal antibodies. Clin Immunother 1994; 1: 199-208.